[go: up one dir, main page]

DK0820990T3 - Benzimidazol-, benzoxazol- og benzothiazolderivater, der er anvendelige som interleukin-1 beta-inhibitorer - Google Patents

Benzimidazol-, benzoxazol- og benzothiazolderivater, der er anvendelige som interleukin-1 beta-inhibitorer

Info

Publication number
DK0820990T3
DK0820990T3 DK97401789T DK97401789T DK0820990T3 DK 0820990 T3 DK0820990 T3 DK 0820990T3 DK 97401789 T DK97401789 T DK 97401789T DK 97401789 T DK97401789 T DK 97401789T DK 0820990 T3 DK0820990 T3 DK 0820990T3
Authority
DK
Denmark
Prior art keywords
optionally substituted
aryl
benzoxazole
benzimidazole
alkyl
Prior art date
Application number
DK97401789T
Other languages
English (en)
Inventor
Bernard Portevin
Nanteuil Guillaume De
Armel Fradin
Jacqueline Bonnet
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0820990T3 publication Critical patent/DK0820990T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK97401789T 1996-07-26 1997-07-24 Benzimidazol-, benzoxazol- og benzothiazolderivater, der er anvendelige som interleukin-1 beta-inhibitorer DK0820990T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9609416A FR2751649B1 (fr) 1996-07-26 1996-07-26 Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK0820990T3 true DK0820990T3 (da) 2001-05-07

Family

ID=9494506

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97401789T DK0820990T3 (da) 1996-07-26 1997-07-24 Benzimidazol-, benzoxazol- og benzothiazolderivater, der er anvendelige som interleukin-1 beta-inhibitorer

Country Status (19)

Country Link
US (1) US5972968A (da)
EP (1) EP0820990B1 (da)
JP (1) JPH1067753A (da)
CN (1) CN1090620C (da)
AT (1) ATE198744T1 (da)
AU (1) AU715751B2 (da)
BR (1) BR9704076A (da)
CA (1) CA2211444C (da)
DE (1) DE69703915T2 (da)
DK (1) DK0820990T3 (da)
ES (1) ES2155660T3 (da)
FR (1) FR2751649B1 (da)
GR (1) GR3035434T3 (da)
HU (1) HUP9701297A1 (da)
NO (1) NO308602B1 (da)
NZ (1) NZ328431A (da)
PL (1) PL321336A1 (da)
PT (1) PT820990E (da)
ZA (1) ZA976655B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602029D0 (en) * 1996-02-01 1996-04-03 Fujisawa Pharmaceutical Co New heterocyclic compounds
FR2766822B1 (fr) * 1997-07-30 2001-02-23 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6248770B1 (en) * 1998-07-09 2001-06-19 Boehringer Ingelheim Pharma Kg Benzimidazoles having antithrombotic activity
DE69823240T2 (de) 1998-10-23 2005-04-28 Toray Industries, Inc. Immunmodulierende arzneimittelzusammenstellung
US6451832B2 (en) 1999-12-23 2002-09-17 Boehringer Ingelheim Pharma Kg Benzimidazoles with antithrombotic activity
AU3653301A (en) 2000-01-28 2001-08-07 Merck & Co., Inc. Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug
US6660858B2 (en) 2001-03-28 2003-12-09 Lion Bioscience Ag 2-aminobenzoxazole derivatives and combinatorial libraries thereof
ATE417830T1 (de) * 2004-11-02 2009-01-15 Pfizer Sulfonylbenzimidazolderivate
PE20070335A1 (es) * 2005-08-30 2007-04-21 Novartis Ag Benzimidazoles sustituidos y metodos para su preparacion
FR2891273B1 (fr) * 2005-09-27 2007-11-23 Aventis Pharma Sa NOUVEAUX DERIVES BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE NOTAMMENT COMME INHIBITEURS DE CMet
WO2010084767A1 (en) * 2009-01-22 2010-07-29 Raqualia Pharma Inc. N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
SG172469A1 (en) 2009-03-05 2011-08-29 Daiichi Sankyo Co Ltd Pyridine derivative
WO2011057208A2 (en) 2009-11-06 2011-05-12 Vanderbilt University Aryl and heteroaryl sulfones as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
AR096654A1 (es) * 2013-06-20 2016-01-27 Ab Science Derivados de benzimidazol como inhibidores selectivos de proteína quinasa

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2290430A1 (fr) * 1974-11-06 1976-06-04 Aries Robert Nouveau mode de synthese d'esters carbamiques derives du benzimidazole
LU75684A1 (da) * 1976-08-27 1978-04-13
DE3067431D1 (en) * 1979-07-20 1984-05-17 Ciba Geigy Ag Coumarine compounds, processes for their manufacture as well as the intermediate products used perse and their utilisation for the dyeing or printing of textiles
GR78209B (da) * 1982-04-15 1984-09-26 May & Baker Ltd
US4430502A (en) * 1982-08-13 1984-02-07 The Upjohn Company Pyridinyl substituted benzimidazoles and quinoxalines
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
IT1222412B (it) * 1987-07-31 1990-09-05 Chiesi Farma Spa Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono
JP2869561B2 (ja) * 1989-05-22 1999-03-10 大塚製薬株式会社 血小板粘着抑制剤
JPH06759B2 (ja) * 1989-09-22 1994-01-05 ファイザー製薬株式会社 新規なベンゾイミダゾール化合物
IE910278A1 (en) * 1990-02-16 1991-08-28 Ici Plc Heterocyclic compounds
JPH08294229A (ja) * 1995-04-20 1996-11-05 Nec Corp 半導体集積回路装置
JPH09169729A (ja) * 1995-12-19 1997-06-30 Green Cross Corp:The 非ペプチド型インターロイキン8拮抗剤
JP3243733B2 (ja) * 1996-08-07 2002-01-07 雪印乳業株式会社 新規イソキノリン誘導体
JP2007024865A (ja) * 2005-06-17 2007-02-01 Renesas Technology Corp 半導体装置
KR100861371B1 (ko) * 2007-06-25 2008-10-01 주식회사 하이닉스반도체 온도센서 및 이를 이용한 반도체 메모리 장치
JP2009058438A (ja) * 2007-08-31 2009-03-19 Toshiba Corp 温度検出回路
JP5888009B2 (ja) * 2012-03-08 2016-03-16 株式会社豊田中央研究所 温度センサ回路

Also Published As

Publication number Publication date
ZA976655B (en) 1998-02-10
US5972968A (en) 1999-10-26
NO973443L (no) 1998-01-27
EP0820990A3 (fr) 1998-07-29
CN1090620C (zh) 2002-09-11
ES2155660T3 (es) 2001-05-16
CA2211444A1 (fr) 1998-01-26
DE69703915T2 (de) 2001-08-02
CA2211444C (fr) 2002-07-09
ATE198744T1 (de) 2001-02-15
FR2751649B1 (fr) 1998-08-28
AU715751B2 (en) 2000-02-10
PL321336A1 (en) 1998-02-02
BR9704076A (pt) 1999-05-11
JPH1067753A (ja) 1998-03-10
CN1174192A (zh) 1998-02-25
NZ328431A (en) 1997-12-19
NO973443D0 (no) 1997-07-25
EP0820990B1 (fr) 2001-01-17
PT820990E (pt) 2001-06-29
AU3017297A (en) 1998-02-05
GR3035434T3 (en) 2001-05-31
DE69703915D1 (de) 2001-02-22
HUP9701297A1 (hu) 1999-09-28
HU9701297D0 (en) 1997-09-29
FR2751649A1 (fr) 1998-01-30
NO308602B1 (no) 2000-10-02
EP0820990A2 (fr) 1998-01-28

Similar Documents

Publication Publication Date Title
DK0820990T3 (da) Benzimidazol-, benzoxazol- og benzothiazolderivater, der er anvendelige som interleukin-1 beta-inhibitorer
ES2059069T3 (es) Nuevos derivados de 1-alcoxi-(2-acilamino-etil)-naftalenos y su procedimiento de preparacion.
MX9303145A (es) 7-(2-aminoetil)benzotiazolonas.
FR2678930B1 (fr) Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
NO910804L (no) Substituerte beta-diketoner.
FI953308A0 (fi) Uudet bentsopyraaniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
DK0803503T3 (da) Syrer og estere af diosmetin og pharmaceutiske sammensætninger indeholdende disse
ATE337023T1 (de) Kontaktlinsenpflegemittel für harte und weiche kontaktlinsen
AU4585096A (en) New tricyclic derivatives, their preparation, their use for the preparation of optically active or racemic colchicine and thiocolchicine and analogues or derivatives and intermediates
ES2063513T3 (es) Nuevos derivados del oxazol, su preparacion y las composiciones farmaceuticas que les contienen.
ATE183183T1 (de) Indol-, indazol- und benzisoxazolderivate zur behandlung von schizophrenia
DE3873562D1 (de) Beta-alkylmelatonine.
FR2760014B1 (fr) Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE3768479D1 (de) 2,3-diaminoacrylonitrilderivate.
DK49487A (da) 9-n-substituerede derivater af erythromycylamin til anvendelse imod infektioner med gram-positive bakterier
SE8704542D0 (sv) New derivatives of cysteine
DK439384D0 (da) Derivater af 4-(3-alkynyloxy-2-hydroxypropyl)-piperazin-1-yl-n-phenylacetamid, fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende disse
NO972943D0 (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
FR2566407B1 (fr) Nouveaux derives de l'isoxazoloquinoleine, procede de preparation, application a titre de medicaments, et compositions les renfermant
YU150690A (sh) Benzotiazinski derivati i postupak za njihovo dobijanje
FI844186A0 (fi) Bis(substituerad metyl) -metylisokinolinderivat och foerfarande foer framstaellning daerav.
ATE35262T1 (de) 6h-dibenz(b,e)(1,4)oxathiepin-derivate und deren herstellung.